V

VenatoRx Pharmaceuticals, Inc.

73 employees

Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.

Basic info

Industry

pharmaceutical manufacturing

Sectors

antivirals
#squashsuperbugs
#battlesuperbugs
drug development
antiinfectives
Pharmaceutical
pharmaceuticals
research
antimicrobialresistance
clinical
Health Care
drug discovery
Medical
#WorkingToFightAMR
antibiotics
biotech

Date founded

2010

Funding rounds raised

Total raised

$42M

from 12 investors over 12 rounds

V

VenatoRx Pharmaceuticals, Inc. raised $34M on April 4, 2022

Investors: AMR Action Fund and Abingworth

V

VenatoRx Pharmaceuticals, Inc. raised $4.1M on November 25, 2019

Investors: CARB-X

V

VenatoRx Pharmaceuticals, Inc. raised $9.3M on February 28, 2019

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

V

VenatoRx Pharmaceuticals, Inc. raised $9.4M on July 27, 2017

Investors: CARB-X

V

VenatoRx Pharmaceuticals, Inc. raised $42M on July 25, 2017

Investors: BioAdvance, Foresite Capital, Versant Ventures and Abingworth

V

VenatoRx Pharmaceuticals, Inc. raised $6M on April 7, 2014

Investors: National Institutes of Health

V

VenatoRx Pharmaceuticals, Inc. raised $3.4M on November 22, 2013

Investors: BioAdvance

V

VenatoRx Pharmaceuticals, Inc. raised $8.9M on October 22, 2013

Investors: Wellcome Trust

FAQ